Suchergebnisse - "Taghour, Mohammed S"

PubPharm (36)

21

Targeting VEGFR-2 by new quinoxaline derivatives : Design, synthesis, antiproliferative assay, apoptosis induction, and in silico studies

enthalten in: Archiv der Pharmazie | 2022

von Alsaif, N. | Mahdy, H. | Alanazi, M. | +6

22

Design, synthesis, anti-proliferative evaluation, docking, and MD simulations studies of new thiazolidine-2,4-diones targeting VEGFR-2 and apoptosis pathway

enthalten in: PloS one | 2022

von Taghour, M. | Elkady, H. | Eldehna, W. | +8

23

Targeting VEGFR‐2 by new quinoxaline derivatives : Design, synthesis, antiproliferative assay, apoptosis induction, and in silico studies

enthalten in: Archiv der Pharmazie | 2022

von Alsaif, N. | Mahdy, H. | Alanazi, M. | +6

24

Discovery of new 3-methylquinoxalines as potential anti-cancer agents and apoptosis inducers targeting VEGFR-2 : design, synthesis, and in silico studies

enthalten in: Journal of enzyme inhibition and medicinal chemistry | 2021

von Alanazi, M. | Alaa, E. | Alsaif, N. | +6

25

Discovery of new VEGFR-2 inhibitors based on bis([1, 2, 4]triazolo)[4,3-a:3',4'-c]quinoxaline derivatives as anticancer agents and apoptosis inducers

enthalten in: Journal of enzyme inhibition and medicinal chemistry | 2021

von Alsaif, N. | Taghour, M. | Alanazi, M. | +6

26

Identification of new [1,2,4]triazolo[4,3-a]quinoxalines as potent VEGFR-2 tyrosine kinase inhibitors : Design, synthesis, anticancer evaluation, and in silico studies

enthalten in: Bioorganic & medicinal chemistry | 2021

von Alsaif, N. | Taghour, M. | Alanazi, M. | +6

27

Design, synthesis and molecular docking of new [1,2,4] triazolo[4,3-a]quinoxaline derivatives as anticancer agents targeting VEGFR-2 kinase

enthalten in: Molecular diversity | 2021

von Alsaif, N. | Elwan, A. | Alanazi, M. | +6

28

Design, synthesis and molecular docking of new [1,2,4] triazolo[4,3-a]quinoxaline derivatives as anticancer agents targeting VEGFR-2 kinase

enthalten in: Molecular diversity | 2021

von Alsaif, N. | Elwan, A. | Alanazi, M. | +6

29

Design, synthesis and molecular docking of new [1,2,4] triazolo[4,3-a]quinoxaline derivatives as anticancer agents targeting VEGFR-2 kinase

enthalten in: Molecular diversity | 2021

von Alsaif, N. | Elwan, A. | Alanazi, M. | +6

30

In Silico Studies of Some Isoflavonoids as Potential Candidates against COVID-19 Targeting Human ACE2 (hACE2) and Viral Main Protease (Mpro)

enthalten in: Molecules (Basel, Switzerland) | 2021

von Alesawy, M. | Abdallah, A. | Taghour, M. | +3